Uyttenhove; Catherine
Patent Applications and Registrations
Patent applications and USPTO patent grants for Uyttenhove; Catherine.The latest application filed is for "tgf-b1 specific antibodies and methods and uses thereof".
- Uyttenhove; Catherine - Brussels BE
- Uyttenhove; Catherine - Louvain-La-Neuve BE
- UYTTENHOVE, CATHERINE - CHAUMONT GISTOUX BE
| Patent | Date |
|---|---|
| Tgf-b1 Specific Antibodies And Methods And Uses Thereof App 20210403545 - Van Snick; Jacques ; et al. | 2021-12-30 |
| TGF- 1 specific antibodies and methods and uses thereof Grant 10,947,303 - Van Snick , et al. March 16, 2 | 2021-03-16 |
| Tgf-beta 3 Specific Antibodies And Methods And Uses Thereof App 20200392221 - VAN SNICK; Jacques ; et al. | 2020-12-17 |
| TGF-.beta.3 specific antibodies and methods and uses thereof Grant 10,723,793 - Van Snick , et al. | 2020-07-28 |
| Tgf- 1 Specific Antibodies And Methods And Uses Thereof App 20190092847 - Van Snick; Jacques ; et al. | 2019-03-28 |
| TGF-.beta.1 specific antibodies and methods and uses thereof Grant 10,035,851 - Van Snick , et al. July 31, 2 | 2018-07-31 |
| Tgf-beta 3 Specific Antibodies And Methods And Uses Thereof App 20180148501 - VAN SNICK; Jacques ; et al. | 2018-05-31 |
| Tgf- 1 Specific Antibodies And Methods And Uses Thereof App 20170137507 - Van Snick; Jacques ; et al. | 2017-05-18 |
| TGF-.beta.1 specific antibodies and methods and uses thereof Grant 9,518,112 - Van Snick , et al. December 13, 2 | 2016-12-13 |
| Tgf-beta1 Specific Antibodies And Methods And Uses Thereof App 20150132319 - Van Snick; Jacques ; et al. | 2015-05-14 |
| Recombinant Anti-Interleukin-9 Antibodies App 20080299134 - Reed; Jennifer Lynne ; et al. | 2008-12-04 |
| Recombinant anti-interleukin-9 antibodies Grant 7,371,383 - Reed , et al. May 13, 2 | 2008-05-13 |
| Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases App 20070048261 - Mettens; Pascal ; et al. | 2007-03-01 |
| Adjuvant Compositions For Vaccines App 20020160011 - BOON, THIERRY ; et al. | 2002-10-31 |
| Method for inhibiting production of IgE by using IL-9 inhibitors Grant 5,246,701 - Dugas , et al. September 21, 1 | 1993-09-21 |
| Antibodies immunoreactive with the T-cell growth factor, P40 Grant 5,157,112 - Van Snick , et al. October 20, 1 | 1992-10-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 